{"schema_version":"secwatch.filing_event.v1","accession":"0001564590-21-049852","form_type":"8-K","ticker":"TXMD","cik":"0000025743","company_name":"TherapeuticsMD, Inc.","filed_at":"2021-10-01T23:59:59+00:00","discovered_at":"2026-05-14T18:04:15.005222+00:00","generated_at":"2026-06-29T00:08:43.332270+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"TherapeuticsMD EVP Operations Edward Borkowski departs effective Sept 30, 2021","bullets":["Mr. Borkowski and company mutually agreed to separation; departure effective September 30, 2021.","Separation treated as 'Good Reason' under Oct 2019 employment agreement; eligible for contractual severance benefits.","No successor named; responsibilities reassigned among remaining executives."],"urls":{"canonical":"https://secwatch.observer/filing/0001564590-21-049852","json":"https://secwatch.observer/filing/0001564590-21-049852.json","markdown":"https://secwatch.observer/filing/0001564590-21-049852.md","text":"https://secwatch.observer/filing/0001564590-21-049852.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/25743/000156459021049852/0001564590-21-049852-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/25743/000156459021049852/txmd-8k_20210930.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T00:08:43.332270+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d709622be2","claim":"Edward Borkowski departed as Executive Vice President, Operations at TherapeuticsMD, Inc..","evidence_excerpt":"On September 30, 2021, TherapeuticsMD, Inc., a Nevada corporation (the “Company”), and Mr. Edward Borkowski, Executive Vice President, Operations of the Company, mutually agreed that Mr. Borkowski would separate from the Company, effective as of such date.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/25743/000156459021049852/0001564590-21-049852-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"separated"},{"label":"Role","value":"Executive Vice President, Operations"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}